A Study of KRN23 in X-linked Hypophosphatemia

NCT00830674 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

X-linked Hypophosphatemia

Interventions

DRUG: Placebo
DRUG: KRN23

Sponsor

Kyowa Kirin Co., Ltd.

Collaborators

[object Object]